| Literature DB >> 15749914 |
Soren Schenk1, Danielle D Kish, Chunshui He, Tarek El-Sawy, Eise Chiffoleau, Chuangqi Chen, Chuangqui Chen, Zihao Wu, Sigrid Sandner, Anton V Gorbachev, Kiyotaka Fukamachi, Peter S Heeger, Mohamed H Sayegh, Laurence A Turka, Robert L Fairchild.
Abstract
Skin but not vascularized cardiac allografts from B6.H-2bm12 mice are acutely rejected by C57BL/6 recipients in response to the single class II MHC disparity. The underlying mechanisms preventing acute rejection of B6.H-2bm12 heart allografts by C57BL/6 recipients were investigated. B6.H-2bm12 heart allografts induced low levels of alloreactive effector T cell priming in C57BL/6 recipients, and this priming was accompanied by low-level cellular infiltration into the allograft that quickly resolved. Recipients with long-term-surviving heart allografts were unable to reject B6.H-2bm12 skin allografts, suggesting potential down-regulatory mechanisms induced by the cardiac allografts. Depletion of CD25+ cells from C57BL/6 recipients resulted in 15-fold increases in alloreactive T cell priming and in acute rejection of B6.H-2bm12 heart grafts. Similarly, reconstitution of B6.Rag(-/-) recipients with wild-type C57BL/6 splenocytes resulted in acute rejection of B6.H-2bm12 heart grafts only if CD25+ cells were depleted. These results indicate that acute rejection of single class II MHC-disparate B6.H-2bm12 heart allografts by C57BL/6 recipients is inhibited by the emergence of CD25+ regulatory cells that restrict the clonal expansion of alloreactive T cells.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15749914 DOI: 10.4049/jimmunol.174.6.3741
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422